# Puma Biotechnology, Inc.: Form 8-K, filed Jun 16, 2026

- Company: [Puma Biotechnology, Inc.](/companies/pbyi.md) (CIK 1401667)
- Form: 8-K
- Filed: 2026-06-16
- Accepted by EDGAR: Jun 16, 2026, 16:06 ET
- Period: 2026-06-11
- Accession: 0001437749-26-020793
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1401667/000143774926020793/pbyi20260613_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1401667/000143774926020793/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1401667/000143774926020793/pbyi20260613_8k.htm

Filed Jun 16, 2026.
Source: SEC EDGAR, the filing index for accession 0001437749-26-020793. Last ingested by Listed: Nov 10, 2026, 03:16 ET. No prices; not investment advice.